Skip to main content
OpenTrials
Completed

NCT Number: NCT00787098

Investigating Modes of Progressive Mobility

The purpose of this study is to compare the effects of specific activities with and without an early therapeutic mobility (ETM) protocol among patients who experience three or more days of mechanical ventilation. A second purpose is to examine staff/delivery system and patient factors that influence the initiation and progression of activity with and without an ETM protocol. The hypothesis is that ETM protocols will result in improved patient outcomes.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The specific aims of this study are to:

  • Compare patient responses to selected modes of therapy (activity) without and with an ETM protocol
  • Molecular responses: markers of inflammation interleukin (IL)-6 and IL-10
  • Physiological responses: peripheral oxygen saturation, heart rate, blood pressure, new dysrhythmias
  • Safety/Unsafe events including pain, fatigue, line or tube dislodgement, fall or near fall
  • Determine the associations between duration and level of activity/ETM achieved and outcomes:
  • occurrence of delirium
  • occurrence of ventilator associated pneumonia
  • occurrence of deep vein thrombosis or pulmonary emboli
  • occurrence of acquired pressure ulcer
  • muscle strength
  • number of days mechanically ventilated
  • discharge location (after ICU)
  • Describe strategies used in the ICU to initiate and implement activity with and without an ETM protocol
  • use of personnel such as registered nurses, physical therapists, respiratory therapist and nursing assistants
  • use of equipment such as a walker, lift device, belt or bed
  • perception of sufficient time and abilities
  • Describe patient factors that are associated with implementation of ETM
  • Potentially modifiable exemplars: sedation, site of vascular access, physician orders
  • Potentially nonmodifiable exemplars: weight, consciousness, hemodynamic instability, terminal condition

This is a prospective, longitudinal, repeated measures study with a control period, run-in period and intervention period. Data will be collected during all three periods for comparison. During the control period, patients will receive standard care. Standard care in this institution does not include a program of progressive or early mobility but does include activities similar to the ETM protocol, implemented at the discretion of the staff. During the run-in period, subjects will receive a mix of standard care and the intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • P:F ratio > 100
  • FiO2 < 60% and PEEP less than 10 cmH20
  • hemodynamic stability ten minutes after turning (i.e., heart rate (HR) and/or systolic blood pressure (BP) changes less than 20% of baseline)
  • baseline (rest) vitals signs of HR 50-110
  • mean arterial pressure (MAP) 60-100 mmHg
  • peripheral oxygenation saturation (SpO2) greater than 88%
  • Sufficient cognition for progression to levels 2-4 of ETM to assist with out of bed positioning or movement
  • a high degree of dependency on others for positioning is acceptable
  • there are no exclusions based on gender or minority status.

Exclusion criteria

  • End-stage muscular dystrophy
  • myasthenia gravis
  • new quadriplegia
  • coma
  • increased intracranial pressure
  • unrepaired hip fracture and multiple lower extremity fractures
  • Patients experiencing active titration of intravenous vasoactive medications (e.g. dopamine, epinephrine, or norepinepherine) will be excluded
  • concurrent use of a continuous lateral rotation bed
  • patients for high risk of death will also be excluded
  • MICU admission following a hospital stay of >9 days in the past months
  • age >80 in the presence of 2 or more life-threatening illnesses
  • diagnosis of an active stage IV malignancy
  • status post cardiac arrest
  • diagnosis of intracerebral hemorrhage requiring mechanical ventilation
  • subjects over 400 pounds can be excluded from mobilization based on the judgment of the bedside nurse or project manager; if the risk for staff or patient harm from moving a patient with excessive weight is considered likely, mobilization will not occur.

Treatment and study plan

ETM protocol

Other

ETM is 4 levels. Level 1, each receives repositioning from lateral to supine positions at even hours, totaling 60 minutes of activity/positioning over 24 hours. If tolerated, two periods of 20 minutes of supine position with a reverse trendelenberg position of 15-20 degrees will be used to promote orthostasis. Level 2 is turning every 2 hours, positioning in reverse trendelenberg at 15-25 degrees as tolerated, active resistance with ICU staff for 20 minutes daily for a total of 60-80 minutes of activity/positioning daily. At Level 3, 2 times 20 minutes of a sitting are added to active ROM and inbed turning (estimated 80-100 total minutes of activity daily). Sitting is in bed or with non-weightbearing assisted transfer to chair with backrest elevation at 75-90 degrees and legs in a dependent position. Level 3 interventions; minimal weight-bearing. Level 4, weight-bearing transfer to chair and ambulation are added to inbed turning.

Primary outcomes

  1. Compare immediate molecular and physiological patient responses to activity with responses to an ETM protocol.

    Time frame: 1, 2, 3, 7, days then weekly

Secondary outcomes

  1. A secondary aim is to identify strategies and conditions that promote or prevent ETM.

    Time frame: 1, 3, 5, 7, days then weekly

Sponsors and collaborators

Lead sponsor

Hill-Rom

Industry

Registry information

Important dates

Study start
2007
Primary completion
2009
Study completion
2009
First posted
Nov 7, 2008
Registry last updated
Jul 3, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.